Literature DB >> 8218991

Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.

D A Muzzillo1, M Imoto, Y Fukuda, Y Koyama, S Saga, Y Nagai, T Hayakawa.   

Abstract

Serum levels of the tissue inhibitor of metalloproteinases-1 (TIMP-1) were measured in 268 patients with liver diseases by means of a one-step sandwich enzyme immunoassay. In the cases of acute hepatitis, chronic active hepatitis (CAH), liver cirrhosis (LC) and hepatocellular carcinoma (HCC), the levels of TIMP-1 were higher than those of the control group. Tissue inhibitor of metalloproteinases-1 levels correlated with type III procollagen peptide and with type IV collagen, indicating TIMP-1 as a useful marker for hepatic fibrosis. Levels of TIMP-1 also correlated with aspartate aminotransferase and alanine aminotransferase levels and showed the highest levels in acute hepatitis. Thus, TIMP-1 might also reflect hepatic inflammation. Serum levels of alpha-fetoprotein and TIMP-1 had a significant positive correlation in patients with HCC. A cut-off level of TIMP-1 between LC and HCC was set at 440 ng/mL, having a low sensitivity and a high specificity. These results suggest the usefulness of TIMP-1 as a tumour marker in cases of HCC where alpha-fetoprotein levels are not elevated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218991     DOI: 10.1111/j.1440-1746.1993.tb01544.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats.

Authors:  Yusuf Yilmaz; Ramazan Kurt; Fatih Eren
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

2.  Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.

Authors:  K M Walsh; P Timms; S Campbell; R N MacSween; A J Morris
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

3.  Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer.

Authors:  Ozgur Kemik; Ahu Sarbay Kemik; Aziz Sümer; Ahmet Cumhur Dulger; Mine Adas; Huseyin Begenik; Ismail Hasirci; Ozkan Yilmaz; Sevim Purisa; Erol Kisli; Sefa Tuzun; Cetin Kotan
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

4.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 5.  Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis.

Authors:  Anshika Jangra; Ashish Kothari; Phulen Sarma; Bikash Medhi; Balram Ji Omar; Karanvir Kaushal
Journal:  Cells       Date:  2022-04-29       Impact factor: 7.666

6.  Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.

Authors:  C K Lindsay; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

7.  Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis.

Authors:  Fiona Oakley; Nathan Trim; Christothea M Constandinou; Weilan Ye; Alane M Gray; Gretchen Frantz; Kenneth Hillan; Tim Kendall; R Christopher Benyon; Derek A Mann; John P Iredale
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

9.  TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice.

Authors:  Nina D Thiele; Jan W Wirth; David Steins; Anja C Koop; Harald Ittrich; Ansgar W Lohse; Johannes Kluwe
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.